New Method Boosts Engineered T-Cell Therapy Effectiveness
Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have identified a method to enhance T-cell therapy by temporarily activating the p53 protein. This discovery, published in Frontiers in Immunology, suggests that treating immune cells with the drug navtemadlin during laboratory preparation can reduce cell exhaustion and improve their ability to eliminate melanoma. Activating p53 … Read more